Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01768962 · ClinicalTrials.gov registry record · Phase 1
Tenofovir Levels Following Local Application of Tenofovir Reduced-Glycerin 1% Gel
A Phase 1 study, sponsored by CONRAD.
- Completed
- Registry status
- Phase 1
- Development phase
- 14
- Enrollment target
NCT01768962: Completed Phase 1 study, sponsored by CONRAD.
NCT01768962 is a Phase 1 study that has completed, run by CONRAD. The registered enrollment target is 14 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01768962, a Phase 1 study, has completed, sponsored by CONRAD.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 14 participants
- Enrollment target
Study Summary
To compare local and systemic pharmacokinetics of tenofovir reduced-glycerin (TFV RG) 1% gel after 2 weeks of daily rectal use and after 2 weeks of daily vaginal use
Primary Outcome
To compare local and systemic pharmacokinetics of tenofovir reduced-glycerin 1% gel after 2 weeks of daily rectal use and after 2 weeks of daily vaginal use
Interventions
- DRUG Once Daily Application of TFV RG 1% Gel - Vaginal
- DRUG Once Daily Application of TFV RG 1% gel - Rectal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2014-04 |
| Est. Completion | 2014-12 |
| Phase | Phase 1 |
What the finished NCT01768962 record still lists
NCT01768962 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 2 interventions - of which Once Daily Application of TFV RG 1% Gel - Vaginal is the first listed.
NCT01768962 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01768962 about?
NCT01768962 is a clinical study titled "Tenofovir Levels Following Local Application of Tenofovir Reduced-Glycerin 1% Gel". To compare local and systemic pharmacokinetics of tenofovir reduced-glycerin (TFV RG) 1% gel after 2 weeks of daily rectal use and after 2 weeks of daily vaginal use
What is the current status of trial NCT01768962?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2014-04. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01768962?
The interventions under investigation include: Once Daily Application of TFV RG 1% Gel - Vaginal (DRUG), Once Daily Application of TFV RG 1% gel - Rectal (DRUG).
Who is sponsoring clinical trial NCT01768962?
This trial is sponsored by CONRAD, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01768962's enrollment target sits among peer trials
14 1844th of 2000 higher than 154 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia